C&F Financial Corporation |
CFFI |
Mar 1, 2021 |
43.50 |
0.00 |
C.H. Robinson Worldwide, Inc. |
CHRW |
Mar 1, 2021 |
92.22 |
+1.51 |
C3.ai Inc |
AI |
Mar 1, 2021 |
121.05 |
0.00 |
C4 Therapeutics, Inc. |
CCCC |
Mar 1, 2021 |
42.39 |
-1.23 |
CA Healthcare Acquisition Corp. - Unit |
CAHCU |
Mar 1, 2021 |
10.17 |
0.00 |
Cabaletta Bio, Inc. |
CABA |
Mar 1, 2021 |
11.47 |
+5.52 |
Cabana Target Drawdown 10 ETF |
TDSC |
Mar 1, 2021 |
24.80 |
+1.22 |
Cabana Target Drawdown 13 ETF |
TDSD |
Mar 1, 2021 |
25.46 |
+1.42 |
Cabana Target Drawdown 16 ETF |
TDSE |
Mar 1, 2021 |
26.12 |
+2.14 |
Cabana Target Drawdown 5 ETF |
TDSA |
Mar 1, 2021 |
24.12 |
+0.90 |
Cabana Target Drawdown 7 ETF |
TDSB |
Mar 1, 2021 |
24.01 |
+1.14 |
Cable One, Inc. |
CABO |
Mar 1, 2021 |
1 924.44 |
+0.50 |
Cabot Corporation |
CBT |
Mar 1, 2021 |
50.71 |
+3.01 |
Cabot Oil & Gas Corp. |
COG |
Mar 1, 2021 |
18.86 |
+1.89 |
CACI International, Inc. Class A |
CACI |
Mar 1, 2021 |
226.92 |
+2.52 |
Cactus, Inc. Class A |
WHD |
Mar 1, 2021 |
34.38 |
+7.88 |
Cadence Bancorporation Class A |
CADE |
Mar 1, 2021 |
21.66 |
+5.56 |
Cadence Design Systems, Inc. |
CDNS |
Mar 1, 2021 |
147.44 |
+4.50 |
Cadiz, Inc. |
CDZI |
Mar 1, 2021 |
11.02 |
+1.38 |
Cae Inc. |
CAE |
Mar 1, 2021 |
29.95 |
+13.15 |
Caesars Entertainment, Inc. |
CZR |
Mar 1, 2021 |
94.06 |
+0.66 |
Caesarstone Ltd. - Ordinary Shares |
CSTE |
Mar 1, 2021 |
12.84 |
+1.82 |
Cai International Inc FXDFR PRF PERPETUAL USD 25 - Ser A |
CAI-A |
Mar 1, 2021 |
26.02 |
-0.12 |
Cai International Inc FXDFR PRF PERPETUAL USD 25 - Ser B |
CAI-B |
Mar 1, 2021 |
26.14 |
-0.83 |
CAI International, Inc. |
CAI |
Mar 1, 2021 |
43.35 |
-1.48 |
Cal-Maine Foods, Inc. |
CALM |
Mar 1, 2021 |
38.22 |
+0.32 |
Caladrius Biosciences, Inc. |
CLBS |
Mar 1, 2021 |
1.92 |
+7.87 |
Calamos Convertible and High Income Fund |
CHY |
Mar 1, 2021 |
15.56 |
+2.30 |
Calamos Convertible Opportunities and Income Fund |
CHI |
Mar 1, 2021 |
14.72 |
+2.44 |
Calamos Dynamic Convertible & Income Fund - |
CCD |
Mar 1, 2021 |
33.62 |
+5.29 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.